Cargando…
Long-term stability of recombinant tissue plasminogen activator at -80 C
BACKGROUND: Recombinant tissue plasminogen activator (tPA) is a thrombolytic widely used clinically in the treatment of acute thrombotic disease such as ischemic stroke, myocardial infarction, and deep venous thrombosis. This has led to much interest in tPA based lytic therapies leading to laborator...
Autores principales: | Shaw, George J, Sperling, Matthew, Meunier, Jason M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711093/ https://www.ncbi.nlm.nih.gov/pubmed/19566947 http://dx.doi.org/10.1186/1756-0500-2-117 |
Ejemplares similares
-
Quality assurance and long‐term stability of a novel 3‐in‐1 X‐ray system for brachytherapy
por: Karius, Andre, et al.
Publicado: (2022) -
Estimation of absorbed dose in clinical radiotherapy linear accelerator beams: Effect of ion chamber calibration and long-term stability
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2013) -
Stability of Recombinant Tissue Plasminogen Activator at −30 °C Over One Year
por: Alkatheri, Abdulmalik
Publicado: (2012) -
Atlantoaxial Stabilization Using C1 and C2 Laminar Screw Fixation
por: Tsuji, Takashi, et al.
Publicado: (2017) -
ViReMa: a virus recombination mapper of next-generation sequencing data characterizes diverse recombinant viral nucleic acids
por: Sotcheff, Stephanea, et al.
Publicado: (2023)